These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29888478)

  • 21. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.
    Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L
    Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
    Rombouts SA; Baillie A; Haber PS; Morley KC
    Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.
    Owens L; Thompson A; Rose A; Gilmore I; Pirmohamed M; Richardson P
    Alcohol; 2017 Aug; 62():11-15. PubMed ID: 28755747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study.
    Morley KC; Logge WB; Fraser I; Morris RW; Baillie AJ; Haber PS
    Eur Neuropsychopharmacol; 2021 May; 46():28-36. PubMed ID: 33735709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
    Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
    Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized, High-Dose Baclofen for Reduction in Alcohol Intake in Persons With High Levels of Consumption.
    Andrade C
    J Clin Psychiatry; 2020 Aug; 81(4):. PubMed ID: 32757504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen.
    Martinez L; Vorspan F; Declèves X; Azuar J; Fortias M; Questel F; Dereux A; Grichy L; Barreteau H; Bellivier F; Lépine JP; Bloch V
    Fundam Clin Pharmacol; 2018 Apr; 32(2):200-205. PubMed ID: 29224234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study.
    Farokhnia M; Schwandt ML; Lee MR; Bollinger JW; Farinelli LA; Amodio JP; Sewell L; Lionetti TA; Spero DE; Leggio L
    Transl Psychiatry; 2017 Apr; 7(4):e1108. PubMed ID: 28440812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers.
    Leggio L; Zywiak WH; Edwards SM; Tidey JW; Swift RM; Kenna GA
    Psychopharmacology (Berl); 2015 Jan; 232(1):233-43. PubMed ID: 24973894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baclofen modulates cardiovascular responses to appetitive cues in treatment-seeking alcohol use disorder individuals.
    Logge WB; Baillie AJ; Haber PS; Morley KC
    Hum Psychopharmacol; 2020 Mar; 35(2):e2722. PubMed ID: 32045501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.
    Rigal L; Alexandre-Dubroeucq C; de Beaurepaire R; Le Jeunne C; Jaury P
    Alcohol Alcohol; 2012; 47(4):439-42. PubMed ID: 22434664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
    Beraha EM; Salemink E; Goudriaan AE; Bakker A; de Jong D; Smits N; Zwart JW; Geest DV; Bodewits P; Schiphof T; Defourny H; van Tricht M; van den Brink W; Wiers RW
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1950-1959. PubMed ID: 27842939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Baclofen for alcohol addiction].
    Helland A; Bramness JG
    Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2132-3. PubMed ID: 22048211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: a meta-analysis of randomized controlled trials.
    Lesouef N; Bellet F; Mounier G; Beyens MN
    Therapie; 2014; 69(5):427-35. PubMed ID: 25230278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
    Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
    Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speaking fluently with baclofen?
    Beraha E; Bodewits P; van den Brink W; Wiers R
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28495786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
    Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
    Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.
    Barrault C; Lison H; Roudot-Thoraval F; Garioud A; Costentin C; Béhar V; Medmoun M; Pulwermacher G; Hagège H; Cadranel JF
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1155-1160. PubMed ID: 28727631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.